Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-01-16

Clinical Trial Update: Selegiline in Outpatient Treatment for Cocaine Dependence - 1 [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating selegiline as outpatient treatment for cocaine dependence has completed, with results summarized in this update.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Selegiline (selegiline)

Snippet

Sponsor: National Institute on Drug Abuse (NIDA) | Conditions: Cocaine-Related Disorders | Phase 2 | Status: COMPLETED